Examination Report |
1 | Authorization Document (POA) | 29 Oct 2009 |
1 | Correspondence | 29 Oct 2009 |
1 | TM-1 | 29 Oct 2009 |
10 | Hearing Notice | 18 Aug 2015 |
11 | Hearing Notice | 07 Mar 2016 |
12 | Hearing Notice | 05 Dec 2016 |
13 | Journal Copy | 16 Jan 2017 |
14 | Certificate | 05 Jun 2017 |
2 | Authorization Document (POA) | 29 Oct 2009 |
2 | Correspondence | 29 Oct 2009 |
2 | TM-1 | 29 Oct 2009 |
3 | Authorization Document (POA) | 29 Oct 2009 |
3 | Correspondence | 29 Oct 2009 |
3 | TM-1 | 29 Oct 2009 |
4 | Additional Representation Sheet | 29 Oct 2009 |
5 | Correspondence | 02 Mar 2010 |
6 | Examination Report | 28 Oct 2010 |
6 | Search Report | 28 Oct 2010 |
7 | Correspondence | 28 Oct 2010 |
7 | Examination Report | 28 Oct 2010 |
8 | Correspondence | 28 Oct 2010 |
8 | Search Report | 28 Oct 2010 |
9 | Hearing Notice | 05 Jan 2015 |
1 | Tribunal ABA Notice for : 1878070 | 4386478 | 04 Jan 2017 | |
2 | O3 NOTICE | 8680451 | 4286356 | 30 Jul 2019 |
The application for Twinbiotic was made on 29 October 2009.
The trademark applicant for Twinbiotic is KEE PHARMA.
Twinbiotic is applied in class(es) 5.
Application for Twinbiotic is on Registered stage.
Application Id allotted to Twinbiotic is 1878070.
Trademark agent or attorney for the application is Inttl Advocare.
Twinbiotic filed with the Intellectual property office as a WORD.